<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04697329</url>
  </required_header>
  <id_info>
    <org_study_id>HUMOSDEC2020</org_study_id>
    <nct_id>NCT04697329</nct_id>
  </id_info>
  <brief_title>Local Infiltration With Levobupivacaine During Laparoscopic Cholecystectomy</brief_title>
  <official_title>Laparoscopic Cholecystectomy: Use of Infiltration With Levobupivacaine and Postoperative Pain: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario de Móstoles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario de Móstoles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial on laparoscopic cholecystectomy. Interventional group:&#xD;
      preincisional infiltration with levobupivacaine. Control group: no local infiltration.&#xD;
&#xD;
      Postoperative pain with numeric rating scale is registered, besides other parameters like&#xD;
      heart rate, blood pressure, rescue analgesia requirements, nausea and vomiting, etc.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 3, 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain assessed by visual numeric scale.</measure>
    <time_frame>24 hours</time_frame>
    <description>Values come from 0 to 10, where 0 means no pain and 10 means the worst imaginable pain. Best outcome would be 0 or close to 0</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative administration of analgesics</measure>
    <time_frame>24 hours</time_frame>
    <description>Record of dose of analgesics needed: nonsteroidal anti-inflamatory drugs, opioid requirements, other analgesics requirements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting episodes</measure>
    <time_frame>24 hours</time_frame>
    <description>Record of episodes of nausea or vomiting during first 24 postoperative hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Laparoscopic Cholecystectomy</condition>
  <condition>Postoperative Pain</condition>
  <condition>Local Infiltration</condition>
  <condition>Levobupivacaine</condition>
  <arm_group>
    <arm_group_label>Local infiltration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No local infiltration</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Preincisional infiltration with levobupivacaine</intervention_name>
    <description>Local, preincisional infiltration of port sites with levobupivacaine 5 mg/ml 20 ml</description>
    <arm_group_label>Local infiltration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective laparoscopic cholecystectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Open surgery&#xD;
&#xD;
          -  Reintervention surgery&#xD;
&#xD;
          -  Drain tube placement&#xD;
&#xD;
          -  Cognitive impairment&#xD;
&#xD;
          -  Allergic reactions to local anesthetics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MANUEL DURÁN POVEDA, MD</last_name>
    <role>Study Director</role>
    <affiliation>H. U. REY JUAN CARLOS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>GIL RODRÍGUEZ CARAVACA, MD</last_name>
    <role>Study Director</role>
    <affiliation>H. F. ALCORCÓN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>JORGE HERRADOR BENITO</last_name>
    <phone>+34645788209</phone>
    <email>JORGE.HERRADOR@GMAIL.COM</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario de Móstoles</name>
      <address>
        <city>Móstoles</city>
        <state>Madrid</state>
        <zip>28935</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JORGE HERRADOR BENITO</last_name>
      <phone>0034645788209</phone>
      <email>JORGE.HERRADOR@GMAIL.COM</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 23, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario de Móstoles</investigator_affiliation>
    <investigator_full_name>JORGE HERRADOR BENITO</investigator_full_name>
    <investigator_title>Principal Investigator. Surgeon.</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic cholecystectomy</keyword>
  <keyword>Postoperative Pain</keyword>
  <keyword>Local Infiltration</keyword>
  <keyword>Levobupivacaine</keyword>
  <keyword>Randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>March 2022. 6 months.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

